Stock Analiz

Envoy Medical, Inc. COCH

Industrial Specialties · IPO 2021 · data as of November 13, 2026

$6.74Market cap $52M
Open the interactive analysis →

Envoy Medical, Inc. (COCH) is a healthcare company listed in the US with a market value of about $52M. In the twelve months to September 30, 2026 it had revenue of $231000 and net income of -$21M, a net margin of -9026.4%.

Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is value (2/5); the weakest is future growth (1/5).

Key numbers: a P/E of 0.9, a 5-year average ROIC of -1128%.

About Envoy Medical

Envoy Medical is listed in the US and classified in industrial specialties, IPO year 2021. Revenue went from $237000 in 2022 to $241000 in 2025, growth of about 0.6% a year. It was profitable in 0 of the last 5 years in our data. Its share count rose by 130% over three years (dilution for shareholders). It spends 5181% of revenue on research and development.

Score: 1.2 / 5

Value2/5
Future growth1/5
Track record1/5
Financial health1/5
Shareholder returns1/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • Strong R&D investment or growth above 20%
  • ROE above 15%
  • More cash than debt, or low debt to equity
  • Pays a dividend

Checks not passed

  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year

Valuation

P/E (TTM)0.9
Forward P/E—
P/FCF—
P/S225.8
P/B—
EV/EBITDA—
PEG—
Dividend yield3.49%
FCF yield-43.0%
Shareholder yield3.5%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)7.1%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-8821.8%
ROIC (5-yr avg.)-1127.8%
Profitable years (of last 10)0
Years paying a dividend2

Financials, last 5 years

Fiscal yearTTM20252024202320222021
Revenue$231000$241000$225000$316000$237000—
Net income-$21M-$24M-$21M-$30M-$16M-$251633
Free cash flow-$22M-$18M-$19M-$17M-$9M—
EPS (diluted)$7.84$-1.23$-1.49$-2.54$-1.57—
Net margin-9026.4%-9857.3%-9242.2%-9469.0%-6718.6%—
ROIC———-1127.8%——

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

What is Envoy Medical’s P/E ratio?

About 0.9, based on the last twelve months of diluted earnings per share.

Does Envoy Medical pay a dividend?

Yes. The dividend yield is about 3.49%, and it has paid dividends for 2 years in our data.

Is Envoy Medical a good stock to buy?

We do not give buy or sell advice. Envoy Medical scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.